ProQR Therapeutics (PRQR) Research & Development (2021 - 2025)
Historic Research & Development for ProQR Therapeutics (PRQR) over the last 5 years, with Q3 2025 value amounting to -$13.0 million.
- ProQR Therapeutics' Research & Development fell 2528.85% to -$13.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.5 million, marking a year-over-year increase of 5483.05%. This contributed to the annual value of $39.3 million for FY2024, which is 4465.11% up from last year.
- As of Q3 2025, ProQR Therapeutics' Research & Development stood at -$13.0 million, which was down 2528.85% from -$12.9 million recorded in Q2 2025.
- Over the past 5 years, ProQR Therapeutics' Research & Development peaked at $92.9 million during Q4 2022, and registered a low of -$15.5 million during Q3 2022.
- In the last 5 years, ProQR Therapeutics' Research & Development had a median value of -$10.7 million in 2021 and averaged $1.4 million.
- Per our database at Business Quant, ProQR Therapeutics' Research & Development skyrocketed by 75180.88% in 2022 and then crashed by 7438.99% in 2024.
- Quarter analysis of 5 years shows ProQR Therapeutics' Research & Development stood at -$14.2 million in 2021, then skyrocketed by 751.81% to $92.9 million in 2022, then plummeted by 50.69% to $45.8 million in 2023, then skyrocketed by 44.91% to $66.4 million in 2024, then tumbled by 119.52% to -$13.0 million in 2025.
- Its last three reported values are -$13.0 million in Q3 2025, -$12.9 million for Q2 2025, and -$13.0 million during Q1 2025.